Optum De-identified Electronic Health Record (EHR) Market Clarity (USA)

Database Contact Data

Vito Perry
Optum USA
Email: vito.perry@optum.com
Phone: +1 801-982-3107

Alternate Contact

If you cannot reach the database manager, please try completing the contact form at: https://www.optum.com/en/business/insights/life-sciences/page.hub5.contact-life-sciences.html

References of Studies Using/Describing Database

1. Geiger CK, Sheinson D, To TM, Jones D, Bonine NG. Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab. Neurol Ther. 2023 Oct;12(5):1709-1728.

2. Schrader R, Posner N, Dorling P, Senerchia C, Chen Y, Beaverson K, Seare J, Garnier N, Walker V, Alvir J, Mahn M, Merla V, Zhang Y, Landis C, Buikema AR. Development and electronic health record validation of an algorithm for identifying patients with Duchenne muscular dystrophy in US administrative claims. J Manag Care Spec Pharm. 2023 Sep;29(9):1033-1044.

3. Lerma EV, Bensink ME, Thakker KM, Lieblich R, Bunke M, Rava A, Wang K, Murphy MV, Oliveri D, Amari DT, Cork DMW, Velez JCQ. Impact of Proteinuria and Kidney Function Decline on Health Care Costs and Resource Utilization in Adults With IgA Nephropathy in the United States: A Retrospective Analysis. Kidney Med. 2023 Jun 25;5(9):100693.

4. Ford JH, Lage MJ, Boye KS, Bae JP, Terrell KA, Bunck MC. Five-year morbidity and mortality rates in a U.S. population with obesity with and without prediabetes. J Diabetes Complications. 2023 May;37(5):108454.

5. Chiorean A, Lyn N, Kabadi S, Blanchon M, Hayat P, Loustalot P, Maski M, Montmerle M, Ponce E. Cluster analysis of kidney function decline among males with Fabry disease in a large United States electronic health records database. Nephrol Dial Transplant. 2023 Apr 14:gfad071.

6. Boye KS, Ford JH, Thieu VT, Lage MJ, Terrell KA. The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes. Diabetes Ther. 2023 Apr;14(4):709-721.

7. Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV Jr. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 2023 Jan 19;24(1):18.

8. Imperato JS, Zou KH, Li JZ, Hassan TA. Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence. Patient Prefer Adherence. 2022 Aug 18;16:2213-2227.

9. Kalilani L, Halpern R, Seare J, Dedeken P. The challenges of assessing effectiveness of lacosamide using electronic medical record databases. Epilepsy & Behavior. 2018 Aug 1;85:195-9.

10. Ammann EM, Kalsekar I, Yoo A, Johnston SS. Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data. Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1092-1100.

Subscribe to